Evidence map›Paper›PMID 34217956›Full record

ArticleJournal of psychosomatic research2021

The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.

Nuno Ferreira, Antonina Mikocka-Walus, Miranda A L van Tilburg, Lesley A Graff, Pragalathan Apputhurai, Manuel Barreiro-de Acosta, Floor Bennebroek Evertsz, Johan Burisch, Bobby Lo, Megan Petrik and 10 more

Open access · greenAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of psychosomatic research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Advances in research on 3C-like protease (3CLRSC medicinal chemistry · 2023
    Review
  4. Article
  5. Article
  6. Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 14 countries.

Nuno FerreiraUniversity of Nicosia, Department of Social Sciences, Nicosia, Cyprus. Electronic address: ferreira.n@unic.ac.cy.
Antonina Mikocka-WalusDeakin University Geelong, School of Psychology, Melbourne, Victoria, Australia.
Miranda A L van TilburgDepartment of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA; College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC, USA; School of Social Work, University of Washington, Seattle, WA, USA.
Lesley A GraffMax Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada.
Pragalathan ApputhuraiSwinburne University of Technology, Melbourne, Victoria, Australia.
Manuel Barreiro-de AcostaIBD Unit, University Hospital Santiago de Compostela, Spain.
Floor Bennebroek EvertszAmsterdam University Medical Centers, the Netherlands.
Johan BurischGastrounit, Medical Division, Hvidovre University Hospital, Denmark.
Bobby LoGastrounit, Medical Division, Hvidovre University Hospital, Denmark.
Megan PetrikUniversity of Minnesota Medical School, USA.
Inês A TrindadeUniversity of Coimbra, Portugal; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Sharon JedelRush University Medical Center, USA.
Gabriele MoserMedical University of Vienna, Austria.
Anna MokrowieckaMedical University of Lodz, Poland.
Charles N BernsteinMax Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada.
Dan DumitrascuIuliu Haţieganu University of Medicine and Pharmacy, Romania.
Alexander C FordLeeds Institute of Medical Research at St. James's, University of Leeds, UK; Leeds Gastroenterology Institute, Leeds Teaching Hospitals Trust, UK.
Andreas StengelDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany; Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany.
Richard GearryUniversity of Otago, Christchurch, New Zealand.
Simon R KnowlesSwinburne University of Technology, Melbourne, Victoria, Australia.
Hvidovre Hospital · DKSwinburne University of Technology · AUUniversity of Manitoba · CAAmsterdam University Medical Centers · NLCharité - Universitätsmedizin Berlin · DEDeakin University · AUIuliu Hațieganu University of Medicine and Pharmacy · ROLeeds Teaching Hospitals NHS Trust · GBMedical University of Lodz · PLMedical University of Vienna · ATRush University Medical Center · USUniversity of Coimbra · PTUniversity of Minnesota Medical Center · USUniversity of Nicosia · CYUniversity of North Carolina at Chapel Hill · USUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and more generally on the well-being of those living with chronic GI conditions.

methodsA longitudinal survey with three time points (baseline, 6-month, and 12-month) will be conducted online. Adult participants with GI disorders from multiple countries will be recruited via patient associations, social media advertising, utilizing snowball sampling. Participants will be invited to complete a battery of questionnaires including demographic and health parameters, and measures of gastrointestinal symptoms, fear of COVID-19, perceived impact of COVID-19, illness perceptions, coping, depression, anxiety, stress, catastrophizing, and quality of life, using validated measures where available. Statistical analyses will include univariate descriptive models, multivariate models utilizing regression, mediation, and moderation, and latent growth models.

conclusionsThis project may present novel information to the field of psychogastroenterology and may provide crucial information regarding the areas of impact for individuals with GI disorders during and following the pandemic. Further, this information can guide healthcare providers and patient associations on how to target support related to the pandemic mental health sequelae for these patients.

Indexed as

Health SurveysInternational CooperationResearch DesignAnxietyCOVID-19DepressionGastrointestinal DiseasesHumansLongitudinal StudiesPandemicsQuality of LifeReproducibility of ResultsStress, PsychologicalAnxietyCOVID-19DepressionGastrointestinal disordersMental healthQuality of lifeStress

Identifiers

PMID34217956
PMCPMC8240440
OpenAlexW3175478213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.